Patents by Inventor Marie-Hélène Charles

Marie-Hélène Charles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10407711
    Abstract: The present invention relates to a method of obtaining peptides from procaryotic and/or eucaryotic cells.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: September 10, 2019
    Assignee: bioMérieux
    Inventors: Marie-Hélène Charles, Jean-Philippe Charrier, Myriam-Laure Cubizolles, Agnès Dupont-Filliard, Véronique Lanet, Florence Rivera, Laurent Veron, Lucie Baujard-Lamotte, Christine Peponnet
  • Publication number: 20190270958
    Abstract: An extraction system includes a support bar including a sample well, a reagent well, at least one washing well, and at least one protection and retention housing; a pipetting element removably mounted on the support bar and extending at least partially into the at least one protection and retention housing; and a filtering and transfer device configured to capture and accumulate microorganisms contained in the sample and transfer the captured and accumulated microorganisms, the filtering and transfer device being removably mounted on the support bar and extending at least partially into the at least one protection and retention housing. The filtering and transfer device includes a hollow body having an elongated shape and including a proximal end portion and a distal end portion; and a filtering element fixed to the distal end portion of the hollow body.
    Type: Application
    Filed: November 15, 2017
    Publication date: September 5, 2019
    Applicant: BIOMÉRIEUX
    Inventors: Patrick BROYER, Marie-Hélène CHARLES, Jérôme BLAZE, Nadine PERROT, Frédéric PINSTON, Hervé ROSTAING
  • Publication number: 20190112632
    Abstract: The present invention relates to a method of obtaining peptides from procaryotic and/or eucaryotic cells.
    Type: Application
    Filed: December 18, 2018
    Publication date: April 18, 2019
    Applicants: bioMérieux, Commissariat à l'Energie Atomique et aux Energies Alternatives
    Inventors: Marie-Hélène CHARLES, Jean-Philippe CHARRIER, Myriam-Laure CUBIZOLLES, Agnès DUPONT-FILLIARD, Véronique LANET, Florence RIVERA, Laurent VERON, Lucie BAUJARD-LAMOTTE, Christine PEPONNET
  • Patent number: 10190148
    Abstract: The present invention relates to a method of obtaining peptides from procaryotic and/or eucaryotic cells.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: January 29, 2019
    Assignees: bioMérieux, Commissariat à l'Energie Atomique et aux Energies Alternatives
    Inventors: Marie-Hélène Charles, Jean-Philippe Charrier, Myriam-Laure Cubizolles, Agnès Dupont-Filliard, Véronique Lanet, Florence Rivera, Laurent Veron, Lucie Baujard-Lamotte, Christine Peponnet
  • Publication number: 20150087003
    Abstract: The present invention relates to a method of obtaining peptides from procaryotic and/or eucaryotic cells.
    Type: Application
    Filed: May 2, 2013
    Publication date: March 26, 2015
    Applicants: bioMérieux, Commissariat à I'Energie Atomique et aux Energies Alternatives
    Inventors: Marie-Hélène Charles, Jean-Philippe Charrier, Myriam-Laure Cubizolles, Agnès Dupont-Filliard, Véronique Lanet, Florence Rivera, Laurent Veron
  • Patent number: 7510843
    Abstract: The invention concerns the use of at least one polypeptide comprising a protein fragment to obtain a diagnostic, prognostic, prophylactic or therapeutic composition for detecting, preventing or treating a pathological condition associated with a degenerative and/or neurological and/or autoimmune disease, said protein being selected among the proteins whereof the peptide sequence in native state corresponds to SEQ ID No 1, SEQ ID No 2, SEQ ID No 3, SEQ ID No 4, SEQ ID No 5, SEQ ID No 6, SEQ ID No 7, SEQ ID No 8, SEQ ID No 9, SEQ ID No 10, SEQ ID No 11, SEQ ID No 12, SEQ ID No 13, SEQ ID No 14, SEQ ID No 15, SEQ ID No 16, SEQ ID No 17, SEQ ID No 18, SEQ ID No 19, SEQ ID No 20, SEQ ID No 21, SEQ ID No 22, SEQ ID No 23, SEQ ID No 24, SEQ ID No 25, SEQ ID No 26, SEQ ID No 27, SEQ ID No 28, and SEQ ID No 29, and the peptide sequences having at least 70% identity, preferably at least 80% identity and advantageously at least 98% identity with any one of the peptide sequences SEQ ID No 1 to SEQ ID No 8 and SEQ ID No 1
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: March 31, 2009
    Assignee: Biomerieux S.A.
    Inventors: Dominique Roecklin, Hanno Kolbe, Marie-Helene Charles, Carine Malcus, Lyse Santoro, Herve Perron
  • Publication number: 20060223121
    Abstract: The invention concerns the use of at least one polypeptide comprising a protein fragment to obtain a diagnostic, prognostic, prophylactic or therapeutic composition for detecting, preventing or treating a pathological condition associated with a degenerative and/or neurological and/or autoimmune disease, said protein being selected among the proteins whereof the peptide sequence in native state corresponds to SEQ ID No 1, SEQ ID No 2, SEQ ID No 3, SEQ ID No 4, SEQ ID No 5, SEQ ID No 6, SEQ ID No 7, SEQ ID No 8, SEQ ID No 9, SEQ ID No 10, SEQ ID No 11, SEQ ID No 12, SEQ ID No 13, SEQ ID No 14, SEQ ID No 15, SEQ ID No 16, SEQ ID No 17, SEQ ID No 18, SEQ ID No 19, SEQ ID No 20, SEQ ID No 21, SEQ ID No 22, SEQ ID No 23, SEQ ID No 24, SEQ ID No 25, SEQ ID No 26, SEQ ID No 27, SEQ ID No 28, and SEQ ID No 29, and the peptide sequences having at least 70% identity, preferably at least 80% identity and advantageously at least 98% identity with any one of the peptide sequences SEQ ID No 1 to SEQ ID No 8 and SEQ ID No 1
    Type: Application
    Filed: June 12, 2006
    Publication date: October 5, 2006
    Applicant: BIOMERIEUX STELHYS
    Inventors: Dominique Roecklin, Hanno Kolbe, Marie-Helene Charles, Carine Malcus, Lyse Santoro, Herve Perron
  • Patent number: 7081345
    Abstract: The invention concerns the use of at least one polypeptide comprising a protein fragment to obtain a diagnostic, prognostic, prophylactic or therapeutic composition for detecting, preventing or treating a pathological condition associated with a degenerative and/or neurological and/or autoimmune disease, said protein being selected among the proteins whereof the peptide sequence in native state corresponds to SEQ ID No 1, SEQ ID No 2, SEQ ID No 3, SEQ ID No 4, SEQ ID No 5, SEQ ID No 6, SEQ ID No 7, SEQ ID No 8, SEQ ID No 9, SEQ ID No 10, SEQ ID No 11, SEQ ID No 12, SEQ ID No 13, SEQ ID No 14, SEQ ID No 15, SEQ ID No 16, SEQ ID No 17, SEQ ID No 18, SEQ ID No 19, SEQ ID No 20, SEQ ID No 21, SEQ ID No 22, SEQ ID No 23, SEQ ID No 24, SEQ ID No 25, SEQ ID No 26, SEQ ID No 27, SEQ ID No 28, and SEQ ID No 29, and the peptide sequences having at least 70% identity, preferably at least 80% identity and advantageously at least 98% identity with any one of the peptide sequences SEQ ID No 1 to SEQ ID No 8 and SEQ ID No 1
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: July 25, 2006
    Assignee: Biomerieux Stelhys
    Inventors: Dominique Roecklin, Hanno Kolbe, Marie-Hélène Charles, Carine Malcus, Lyse Santoro, Hervé Perron
  • Patent number: 6632615
    Abstract: The invention concerns a method for isolating a target biological material contained in a sample, which consists in providing a capture phase comprising an organic molecule having at least a reactive function and at least a protein material capable of recognizing or binding, specifically and directly or indirectly, with the target biological material, said protein material having a specific covalent binding site with the organic molecule reactive function, consisting of at least a tag comprising at least six contiguous lysine, or lysine derivative residues, the method consists in contacting said target biological material with at least the capture phase; and detecting the target biological material fixed on the capture phase: The invention also concerns the capture and detection phases, and a reagent containing them.
    Type: Grant
    Filed: April 21, 1999
    Date of Patent: October 14, 2003
    Assignee: Bio Merieux
    Inventors: Francois Mallet, Thierry DeLair, Catherine Ladaviere, Armelle Novelli-Rousseau, Marie-Helene Charles
  • Publication number: 20020192840
    Abstract: The invention concerns a method for isolating a target biological material contained in a sample, which consists in providing a capture phase comprising an organic molecule having at least a reactive function and at least a protein material capable of recognizing or binding, specifically and directly or indirectly, with the target biological material, said protein material having a specific covalent binding site with the organic molecule reactive function, consisting of at least a tag comprising at least six contiguous lysine, or lysine derivative residues, the method consists in contacting said target biological material with at least the capture phase; and detecting the target biological material fixed on the capture phase: The invention also concerns the capture and detection phases, and a reagent containing them.
    Type: Application
    Filed: April 21, 1999
    Publication date: December 19, 2002
    Inventors: FRANCOIS MALLET, THIERRY DELAIR, CATHERINE LADAVIERE, ARMELLE NOVELLI-ROUSSEAU, MARIE-HELENE CHARLES
  • Publication number: 20020155496
    Abstract: The invention concerns a saturated or unsaturated abietane derivative of general formula (I) wherein: Z is selected among —COOR5, —CONR1R2, —COONR3R4, —COR6, —CON, —COOR5, —CHOHR7, —SR8, —OR8, —CN, —CNO, —CNS, —NCO, —NCS and —R1R2CR9; wherein R1, R2, R3 and R4 represent a hydrogen atom, a C1-C10 alkyl, a C6-C20 aryl optionally substituted, a C7-C10 alkene, a C1-C10 alkyne, or an aminoacyl or peptidyl optionally substituted; or R1 and R2 or R3 and R4 together form a cycle or a heterocycle; R5 represents a hydrogen, a C1-C10 alkyl, a C1-C10 alkene, a C1-C10 alkyne, or an aryl optionally substituted into C6-C20; R6 represents a hydrogen, a halogen, a C1-C10 alkyl, a C1-C10 alkene, a C1-C10 alkyne, or an aryl optionally substituted into C6-C20; R7 represents a hydrogen, a C1-C10 alkyl, a C1-C10 alkene, or a C1-C10 alkyne; R8 represents a hydrogen, a C1-C10 alkyl, a C1-C10 alkene, or a C1-C10 alkyne; and R9 is selected among
    Type: Application
    Filed: January 30, 2001
    Publication date: October 24, 2002
    Inventors: Marie Helene Charles, Nadia Piga, Nicole Battail-Poirot, Laurent Veron, Thierry Delair, Bernard Mandrand
  • Patent number: 6033853
    Abstract: Kit for detecting a specific target nucleic acid sequence using a labeled probe with signal amplification, which comprises in containers (i) a probe labeled with a tracer (ii) a suspension of insoluble particles on which are immobilized at least one series of oligonucleotide units all of which are identical and contain at least one sequence that specifically hybridize with the target nucleic acid sequence and at one sequence that specifically hybridize with tracer labeled probe. A method using the kit is also described.
    Type: Grant
    Filed: January 8, 1997
    Date of Patent: March 7, 2000
    Assignee: Bio Merieux
    Inventors: Thierry Delair, Abdelhamid Elaissari, Marie-Helene Charles, Bernard Mandrand
  • Patent number: 6017707
    Abstract: Methods for the detection of a nucleotide sequence of interest comprising at least one nucleotide probe marked with a tracer. The methods include a reagent essentially comprising a linear backbone copolymer having lateral substituents, whose chain consists of a first type of repetitive unit and at least one other type of repetitive unit, in which at least one part of the units of the first type have a lateral substituent comprising a nucleotide unit, such a lateral substituent not being present on the other types of units. Each of said nucleotide units, all of which are identical, comprise at least one nucleotide sequence capable of hybridizing with said sequence of interest and nucleotide sequence capable of hybridizing with a probe, the reagent containing on average more than two of said nucleotide units, in molar equivalents, per mole of polymer. Such a reagent enables signal amplification to be obtained, and therefor lowers the sensitivity threshold.
    Type: Grant
    Filed: June 6, 1997
    Date of Patent: January 25, 2000
    Assignee: Bio Merieux
    Inventors: Bernard Mandrand, Philippe Cros, Thierry Delair, Marie-Helene Charles, Marie-Noelle Erout, Christian Pichot
  • Patent number: 5760166
    Abstract: Water-soluble compound derived from a homopolymer or copolymer of maleic anhydride having available anhydride functional groups and hydrolyzed anhydride functional groups, wherein the hydrolyzed anhydride functional groups consist of carboxyl functional groups and functional groups derived from carboxyl functional groups carrying a residue of a compound corresponding to the formula I:C.sub.x H.sub.y A.sub.z O.sub.tin which:A is the nitrogen atom of a primary, secondary or tertiary amine functional group or the sulfur atom of a thiol functional group,x, z and t, independently of each other, are non-zero integers, andy is a non-zero integer, not less than 5 when A is a nitrogen atom and not less than 4 when A is a sulfur atom.
    Type: Grant
    Filed: February 2, 1996
    Date of Patent: June 2, 1998
    Assignee: Bio Merieux
    Inventors: Marie-Helene Charles, Thierry Delair, Monique Jaubert, Bernard F. Mandrand
  • Patent number: 5723344
    Abstract: Device for capturing a target molecule for the purpose of detecting it and/or assaying it, including a solid support on which is immobilized a ligand, the ligand being provided in the form of a conjugate resulting from the covalent coupling of a polymer with a plurality of molecules of the ligand. The polymer is an N-vinylpyrrolidone copolymer, and the conjugate is immobilized on the solid support by adsorption.When the ligand is capable of forming a complex with the target, the device is specific for a given target. When the device comprises, in addition, a bifunctional reagent capable of forming a complex, on the one hand, with the ligand and, on the other hand, with the target, the support on which the ligand is immobilized constitutes a universal capturing system.
    Type: Grant
    Filed: June 24, 1994
    Date of Patent: March 3, 1998
    Assignee: Bio Merieux
    Inventors: Claude Mabilat, Philippe Cros, Bernard Mandrand, Marie-Helene Charles, Marie-Noelle Erout, Christian Pichot
  • Patent number: 5695936
    Abstract: Methods for the detection of a nucleotide sequence of interest comprising at least one nucleotide probe marked with a tracer. The methods comprise use of a reagent essentially comprising a linear backbone copolymer having lateral substituents, whose chain consists of a first type of repetitive unit and at least one other type of repetitive unit, in which at least one part of the units of the first type have a lateral substituent comprising a nucleotide unit, such a lateral substituent not being present on the other types of units. Each of said nucleotide units, all of which are identical, comprise at least one nucleotide sequence capable of hybridizing with said sequence of interest and nucleotide sequence capable of hybridizing with a probe, the reagent containing on average more than two of said nucleotide units, in molar equivalents, per mole of polymer. Such a reagent enables signal amplification to be obtained, and therefor lowers the sensitivity threshold.
    Type: Grant
    Filed: June 14, 1995
    Date of Patent: December 9, 1997
    Assignee: Bio Merieux
    Inventors: Bernard Mandrand, Philippe Cros, Thierry Delair, Marie-Helene Charles, Marie-Noelle Erout, Christian Pichot
  • Patent number: 5489653
    Abstract: Water-soluble compound derived from a homopolymer or copolymer of maleic anhydride having available anhydride functional groups and hydrolyzed anhydride functional groups, wherein the hydrolyzed anhydride functional groups consist of carboxyl functional groups and functional groups derived from carboxyl functional groups carrying a residue of a compound corresponding to the formula I:C.sub.x H.sub.y A.sub.z O.sub.tin which:A is the nitrogen atom of a primary, secondary or tertiary amine functional group or the sulfur atom of a thiol functional group,x, z and t, independently of each other, are non-zero integers, andy is a non-zero integer, not less than 5 when A is a nitrogen atom and not less than 4 when A is a sulfur atom.
    Type: Grant
    Filed: March 16, 1993
    Date of Patent: February 6, 1996
    Assignee: Bio Merieux
    Inventors: Marie-Helene Charles, Thierry Delair, Monique Jaubert, Bernard F. Mandrand
  • Patent number: 5439972
    Abstract: Water-soluble compounds derived from a homopolymer or copolymer of maleic anhydride, and applications of the said compounds to supporting biological moleculesWater-soluble compound derived from a homopolymer or copolymer of maleic anhydride having available anhydride functional groups and hydrolyzed anhydride functional groups, wherein the hydrolyzed anhydride functional groups consist of carboxyl functional groups and functional groups derived from carboxyl functional groups carrying a residue of a compound corresponding to the formula I:C.sub.x H.sub.y A.sub.z O.sub.tin which:- A is the nitrogen atom of a primary, secondary or tertiary amine functional group or the sulfur atom of a thiol functional group,- x, z and t, independently of each other, are non-zero integers, and- y is a non-zero integer, not less than 5 when A is a nitrogen atom and not less than 4 when A is a sulfur atom.
    Type: Grant
    Filed: October 12, 1994
    Date of Patent: August 8, 1995
    Assignee: Bio Merieux
    Inventors: Marie-Helene Charles, Thierry Delair, Monique Jaubert, Bernard F. Mandrand